News and Trends 26 Sep 2022
Acticor Biotech enrolls first U.S. patient in study for people with acute ischemic stroke
…inclusion in the United States in ACTISAVE study. Glenzocimab has significant potential for improvement in patients with ischemic stroke, especially those undergoing mechanical thrombectomy. “We urgently need new drugs in…